KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Analyst Ratings
USA - NASDAQ:KZIA - US48669G3039 - ADR
7.39 USD
+0.06 (+0.82%)
ChartMill assigns a Buy % Consensus number of 83% to KZIA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.83. This target is 127.74% above the current price.
KZIA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KZIA.
In the previous month the buy percentage consensus was at a similar level.
KZIA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-02 | Maxim Group | Maintains | Buy -> Buy |
| 2025-07-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-11 | Maxim Group | Maintains | Buy -> Buy |
| 2025-02-06 | Maxim Group | Initiate | Buy |
| 2024-07-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-11 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-08-02 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-08-02 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-10-14 | Maxim Group | Initiate | Buy |
KAZIA THERAPEUTICS-SPON ADR / KZIA FAQ
Can you provide the average price target for KAZIA THERAPEUTICS-SPON ADR stock?
8 analysts have analysed KZIA and the average price target is 16.83 USD. This implies a price increase of 127.74% is expected in the next year compared to the current price of 7.39.
What is the consensus rating for KAZIA THERAPEUTICS-SPON ADR (KZIA) stock?
The consensus rating for KAZIA THERAPEUTICS-SPON ADR (KZIA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover KAZIA THERAPEUTICS-SPON ADR (KZIA) stock?
The number of analysts covering KAZIA THERAPEUTICS-SPON ADR (KZIA) is 8.